Aug 27, 2026
53:50
For every 50 shares held, investors received 53. The price per share adjusted from $32.50 to $30.66.
The split itself did not change the total investment value.
Sinphar Pharmaceutical Co. Ltd. (TWSE:1734) operates in the Pharmaceuticals: major industry.
Sinphar Pharmaceutical Co. Ltd. company overviewSinphar Pharmaceutical Co. Ltd.'s most recent stock split was on August 27, 2026. It was a 53-for-50 forward split, so shareholders received 53 shares for every 50 they held.
Sinphar Pharmaceutical Co. Ltd. (TWSE:1734) has split its stock 12 times: a 21-for-20 split on July 10, 2003, a 53-for-50 split on June 17, 2004, a 107-for-100 split on July 13, 2005, a 199-for-193 split on September 14, 2005, a 27-for-25 split on August 3, 2006, a 683-for-660 split on July 27, 2010, a 1014-for-995 split on November 15, 2011, a 27-for-25 split on August 28, 2014, a 26-for-25 split on September 1, 2016, a 27-for-25 split on September 4, 2024, a 21-for-20 split on September 2, 2025, and a 53-for-50 split on August 27, 2026.
Sinphar Pharmaceutical Co. Ltd. has split its stock 12 times. This history records 12 forward splits between July 10, 2003 and August 27, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Sinphar Pharmaceutical Co. Ltd.'s 53-for-50 split on August 27, 2026, every 50 shares became 53 shares.
Sinphar Pharmaceutical Co. Ltd. has not announced a new split in our records. Its most recent split was on August 27, 2026, less than a year ago. Companies announce splits in advance, and any new TWSE:1734 split will appear on this page.
Already premium?